The total return over the past 12 months is -23.90% vs. +16.94% for the S&P 500. So far it's up -42.90% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (23.90%) | (24.20%) | (46.06%) | (26.29%) | N/A | N/A |
| Total Return CAGR | (23.90%) | (24.20%) | (46.06%) | (26.29%) | N/A | N/A |
| Revenue CAGR | +15.46% | (5.92%) | +5.39% | +35.62% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Fortress Biotech, Inc. (FBIO)
| Year | Start price | End price | FBIO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.66 | $2.09 | (42.90%) | +14.51% | (57.41%) |
| 2025 | $2.03 | $3.66 | +80.30% | +17.72% | +62.58% |
| 2024 | $3.01 | $2.03 | (32.56%) | +24.89% | (57.45%) |
| 2023 | $9.90 | $3.01 | (69.60%) | +26.19% | (95.79%) |
| 2022 | $37.50 | $9.90 | (73.60%) | (18.17%) | (55.43%) |
| 2021 | $47.55 | $37.50 | (21.14%) | +28.74% | (49.88%) |
| 2020 | $38.55 | $47.55 | +23.35% | +18.37% | +4.98% |
| 2019 | $12.90 | $38.55 | +198.84% | +31.22% | +167.62% |
| 2018 | $59.85 | $12.90 | (78.45%) | (4.56%) | (73.89%) |
| 2017 | $40.50 | $59.85 | +47.78% | +21.70% | +26.08% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
